News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rosenberger Brian
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 14,926 shares
@ $0
Paid exercise price by delivering 5,145 shares
@ $0.5965, valued at
$3.1k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Sold 12,663 shares
@ $0.5978, valued at
$7.6k
Granted 120,000 shares
@ $0 |
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 shares
@ $0
Granted 90,000 options to buy
@ $2.41, valued at
$216.9k
|
|
| 01/25/2021 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 37,000 shares
@ $0
Granted 55,000 options to buy
@ $3.58, valued at
$196.9k
|
|
| 02/03/2020 |
4
| Rosenberger Brian (VP, Commercial & Business Dev.) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 48,000 options to buy
@ $5.05, valued at
$242.4k
Granted 10,000 options to buy
@ $5.05, valued at
$50.5k
|
|
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2018 |
4
| Rosenberger Brian (VP, Commercial) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 42,000 options to buy
@ $11.71, valued at
$491.8k
|
|
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|